Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Current Opinion in Obstetrics & Gynecology|March 25, 2020
Anti-Müllerian hormone as a qualitative marker - or just quantity?Alexander Kotlyar, David B SeiferJournal of Assisted Reproduction and Genetics|September 7, 2014
Is AMH a regulator of follicular atresia?David B Seifer, Zaher MerhiReproductive Biology and Endocrinology : RB&E|June 16, 2016
Biosimilar FSH preparations- are they identical twins or just siblings?Raoul Orvieto, David B SeiferJournal of Clinical Medicine|July 13, 2024
Current Status of Ovarian and Endometrial Biomarkers in Predicting ART OutcomesMichelle Volovsky, David B SeiferInternational Journal of Endocrinology|December 19, 2013
Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserveReshef Tal, David B SeiferFrontiers in Endocrinology|February 26, 2021
Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A ReviewAlexander M Kotlyar, David B SeiferReproductive Biology and Endocrinology : RB&E|May 10, 2025
United States racial/ethnic disparities in PGT-A use: an analysis of 2014-2020 SART CORS databaseAkailah Mason-Otey, David B SeiferReproductive Biology and Endocrinology : RB&E|August 1, 2023
Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomesAlexander M Kotlyar, David B SeiferObstetrics and Gynecology|May 2, 2024
Assessment of a Decade of Change in U.S. Assisted Reproductive Technology Cumulative Live-Birth Rates: 2004-2009 Compared With 2014-2020Sarah F Wang, David B SeiferFertility and Sterility|June 15, 2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceDavid B Seifer, David T MaclaughlinPageof 11